Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type
1 clinical trials · Condition
◉ Watch Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type
| Record | Firm | Date |
|---|---|---|
| A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity ) (NCT02059642) | Alcobra Ltd. | 2014-03-01 |
Track Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type automatically
Every clearance here is in the API, with alerts when new ones post.